Attovia Therapeutics Files for US IPO to Advance Pipeline of Immune Disease Therapies Written By sheeba farhat19 July 2026 10:15 AM ISTBengaluru: Biopharmaceutical ​company Attovia Therapeutics on ​Tuesday filed for an initial ​public offering in the United States, seeking to raise...
Zydus Lifesciences to Invest Up to Rs 43 Crore in Sri Lanka Pharma Joint Venture Written By Parthika Patel28 Jun 2026 11:00 AM ISTNew Delhi: Zydus Lifesciences Limited has entered into a Share Subscription and Shareholders' Agreement (SSSHA) with Sunshine Healthcare Lanka Limited...
Global Investors Acquire 3% Stake in Anthem Biosciences for Rs 1,275 Crore Written By sheeba farhat22 Jun 2026 5:31 PM ISTNew Delhi: Global financial institutions, including Societe Generale, Prudential Hong Kong and Ghisallo Capital Management, have acquired a combined 3...
Kiran Shaw Backed Cancer Therapy Startup Immuneel Secures Rs 100 Crore in Series B Funding Written By Parthika Patel9 Jun 2026 9:16 PM ISTNew Delhi: Immuneel Therapeutics, a Bengaluru-based cell and gene therapy company backed by investors including Eight Roads Ventures and co-founded by...
Shilpa Medicare Unit Invests Euro 7 Million in Brain Cancer Drug Developer Gate2Brain Written By Parthika Patel5 Jun 2026 4:17 PM ISTNew Delhi: Shilpa Biocare Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited, has announced a strategic equity partnership with...
Zydus Lifesciences Acquires France-Based Aptitude Orthopedie Written By Parthika Patel2 May 2026 1:00 PM ISTAhmedabad: Zydus Lifesciences Limited has announced the acquisition of 100% share capital of France-based Aptitude Orthopedie through its indirect...
AstraZeneca Commits USD 405 Million to UK Life Sciences Amid Policy Shift Written By sheeba farhat30 April 2026 6:13 PM ISTLondon: Prime Minister Keir ​Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 million) in...
Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push Written By sheeba farhat28 April 2026 8:03 PM ISTBengaluru: Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to USD2.3 billion in cash, as the U.S....
Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal Written By sheeba farhat27 April 2026 12:50 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited and Organon & Co. has announced that they have entered into a definitive agreement under which...
Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation Written By Parthika Patel25 April 2026 5:40 PM ISTNew Delhi: A consortium of private equity investors, led by healthcare-focused Quadria Capital, is assessing the acquisition of an 80-85% stake in...
Sun Pharma Submits Binding USD 13 Billion Bid for Organon, Deal May Be India's Largest Pharma Acquisition: Report Written By Parthika Patel24 April 2026 1:00 PM ISTNew Delhi: Sun Pharmaceutical Industries has emerged as the frontrunner in the race to acquire US-based Organon & Co. after submitting a binding...
Rubicon Research Acquires 85% Stake in Arinna for Rs 176 Cr, Enters CNS Market Written By Parthika Patel16 April 2026 8:38 PM ISTNew Delhi: Rubicon Research Limited has acquired an 85% equity stake in Arinna Lifesciences Limited for approximately Rs 175.92 crore, valuing the...
